ID   STK19_HUMAN             Reviewed;         368 AA.
AC   P49842; A6NF95; A6NFW8; B0QZR5; Q13159; Q31617; Q5JP77; Q5ST72;
AC   Q5ST75;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   15-MAR-2017, entry version 147.
DE   RecName: Full=Serine/threonine-protein kinase 19;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein G11;
DE   AltName: Full=Protein RP1;
GN   Name=STK19; Synonyms=G11, RP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 3 AND 4).
RX   PubMed=8012361; DOI=10.1093/hmg/3.3.481;
RA   Sargent C.A., Anderson M.J., Hsieh S.-L., Kendall E.,
RA   Gomez-Escobar N., Campbell R.D.;
RT   "Characterisation of the novel gene G11 lying adjacent to the
RT   complement C4A gene in the human major histocompatibility complex.";
RL   Hum. Mol. Genet. 3:481-488(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2).
RX   PubMed=8132574;
RA   Liming S., Wu L., Sanlioglu S., Chen R., Mendoza A.R., Dangel A.W.,
RA   Carroll M.C., Zipf W.B., Yu C.;
RT   "Structure and genetics of the partially duplicated gene RP located
RT   immediately upstream of the complement C4A and the C4B genes in the
RT   HLA class III region. Molecular cloning, exon-intron structure,
RT   composite retroposon, and breakpoint of gene duplication.";
RL   J. Biol. Chem. 269:8466-8476(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLY-311.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING
RP   (ISOFORM 4).
RC   TISSUE=Blood;
RX   PubMed=8575831; DOI=10.1007/BF00587313;
RA   Ulgiati D., Townend D.C., Christiansen F.T., Dawkins R.L.,
RA   Abraham L.J.;
RT   "Complete sequence of the complement C4 gene from the HLA-A1, B8,
RT   C4AQ0, C4B1, DR3 haplotype.";
RL   Immunogenetics 43:250-252(1996).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=9812991; DOI=10.1074/jbc.273.47.30954;
RA   Gomez-Escobar N., Chou C.-F., Lin W.-W., Hsieh S.-L., Campbell R.D.;
RT   "The G11 gene located in the major histocompatibility complex encodes
RT   a novel nuclear serine/threonine protein kinase.";
RL   J. Biol. Chem. 273:30954-30960(1998).
RN   [8]
RP   INTERACTION WITH BAG1.
RC   TISSUE=T-cell;
RX   PubMed=15986447; DOI=10.1002/ijc.21259;
RA   Wadle A., Mischo A., Henrich P.P., Stenner-Lieven F., Scherer C.,
RA   Imig J., Petersen G., Pfreundschuh M., Renner C.;
RT   "Characterization of Hap/BAG-1 variants as RP1 binding proteins with
RT   antiapoptotic activity.";
RL   Int. J. Cancer 117:896-904(2005).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-89; GLY-311 AND VAL-331.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Seems to be a protein kinase. In vitro it can
CC       phosphorylate casein-alpha on serine and threonine residues and
CC       histones on serine residues.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Note=Divalent metal cations. Has a preference for Mn(2+).;
CC   -!- SUBUNIT: The N-terminus interacts with BAG1.
CC       {ECO:0000269|PubMed:15986447}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=G11-Z;
CC         IsoId=P49842-1; Sequence=Displayed;
CC       Name=2; Synonyms=G11-Z-short;
CC         IsoId=P49842-2; Sequence=VSP_004433;
CC       Name=3; Synonyms=G11-Y;
CC         IsoId=P49842-3; Sequence=VSP_004432;
CC       Name=4; Synonyms=G11-Y-short;
CC         IsoId=P49842-4; Sequence=VSP_004432, VSP_004433;
CC   -!- TISSUE SPECIFICITY: Monocytes, hepatocytes, epithelial cells, T-
CC       and B-lymphocytes.
CC   -!- SIMILARITY: Belongs to the STK19 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X77474; CAA54622.1; -; Genomic_DNA.
DR   EMBL; X77489; CAA54622.1; JOINED; Genomic_DNA.
DR   EMBL; X77490; CAA54622.1; JOINED; Genomic_DNA.
DR   EMBL; X77491; CAA54622.1; JOINED; Genomic_DNA.
DR   EMBL; X77474; CAA54623.1; -; Genomic_DNA.
DR   EMBL; X77489; CAA54623.1; JOINED; Genomic_DNA.
DR   EMBL; X77490; CAA54623.1; JOINED; Genomic_DNA.
DR   EMBL; X77491; CAA54623.1; JOINED; Genomic_DNA.
DR   EMBL; X77386; CAA54565.1; -; mRNA.
DR   EMBL; L26261; AAA20120.1; -; Genomic_DNA.
DR   EMBL; L26260; AAA20122.1; -; mRNA.
DR   EMBL; AF019413; AAB67976.1; -; Genomic_DNA.
DR   EMBL; AL049547; CAB89303.1; -; Genomic_DNA.
DR   EMBL; AL049547; CAB89304.1; -; Genomic_DNA.
DR   EMBL; AL662849; CAI17468.2; -; Genomic_DNA.
DR   EMBL; AL662849; CAI17470.2; -; Genomic_DNA.
DR   EMBL; AL844853; CAI41868.1; -; Genomic_DNA.
DR   EMBL; CR753822; CAM26056.1; -; Genomic_DNA.
DR   EMBL; BX679671; CAM26056.1; JOINED; Genomic_DNA.
DR   EMBL; CR753822; CAM26057.1; -; Genomic_DNA.
DR   EMBL; BX679671; CAM26057.1; JOINED; Genomic_DNA.
DR   EMBL; BX679671; CAM26064.1; -; Genomic_DNA.
DR   EMBL; CR753822; CAM26064.1; JOINED; Genomic_DNA.
DR   EMBL; BX679671; CAM26065.1; -; Genomic_DNA.
DR   EMBL; CR753822; CAM26065.1; JOINED; Genomic_DNA.
DR   EMBL; CR759782; CAQ07123.1; -; Genomic_DNA.
DR   EMBL; CR759782; CAQ07124.1; -; Genomic_DNA.
DR   EMBL; AL645922; CAQ09282.1; -; Genomic_DNA.
DR   EMBL; AL645922; CAQ09283.1; -; Genomic_DNA.
DR   EMBL; CR753845; CAQ10913.1; -; Genomic_DNA.
DR   EMBL; CR753845; CAQ10914.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03566.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03567.1; -; Genomic_DNA.
DR   EMBL; U24578; AAA99716.1; -; Genomic_DNA.
DR   CCDS; CCDS34417.1; -. [P49842-2]
DR   CCDS; CCDS4733.1; -. [P49842-1]
DR   PIR; B53439; A53439.
DR   RefSeq; NP_004188.1; NM_004197.1. [P49842-2]
DR   RefSeq; NP_115830.1; NM_032454.1. [P49842-1]
DR   UniGene; Hs.654371; -.
DR   ProteinModelPortal; P49842; -.
DR   BioGrid; 114383; 8.
DR   IntAct; P49842; 6.
DR   MINT; MINT-1032657; -.
DR   STRING; 9606.ENSP00000364482; -.
DR   iPTMnet; P49842; -.
DR   PhosphoSitePlus; P49842; -.
DR   BioMuta; STK19; -.
DR   DMDM; 19860281; -.
DR   EPD; P49842; -.
DR   MaxQB; P49842; -.
DR   PaxDb; P49842; -.
DR   PeptideAtlas; P49842; -.
DR   PRIDE; P49842; -.
DR   DNASU; 8859; -.
DR   Ensembl; ENST00000375331; ENSP00000364480; ENSG00000204344. [P49842-2]
DR   Ensembl; ENST00000375333; ENSP00000364482; ENSG00000204344. [P49842-1]
DR   Ensembl; ENST00000383327; ENSP00000372817; ENSG00000206342.
DR   Ensembl; ENST00000424104; ENSP00000393272; ENSG00000236250. [P49842-2]
DR   Ensembl; ENST00000425138; ENSP00000395028; ENSG00000234947. [P49842-2]
DR   Ensembl; ENST00000426802; ENSP00000389352; ENSG00000226257. [P49842-2]
DR   Ensembl; ENST00000431383; ENSP00000403479; ENSG00000226033. [P49842-1]
DR   Ensembl; ENST00000433397; ENSP00000395864; ENSG00000234947. [P49842-1]
DR   Ensembl; ENST00000438256; ENSP00000391798; ENSG00000236250. [P49842-1]
DR   Ensembl; ENST00000444147; ENSP00000399915; ENSG00000226033. [P49842-2]
DR   Ensembl; ENST00000452688; ENSP00000413766; ENSG00000226257. [P49842-1]
DR   GeneID; 8859; -.
DR   KEGG; hsa:8859; -.
DR   UCSC; uc003nyv.4; human. [P49842-1]
DR   CTD; 8859; -.
DR   DisGeNET; 8859; -.
DR   GeneCards; STK19; -.
DR   H-InvDB; HIX0058171; -.
DR   HGNC; HGNC:11398; STK19.
DR   HPA; HPA031510; -.
DR   HPA; HPA031511; -.
DR   HPA; HPA068559; -.
DR   MIM; 604977; gene.
DR   neXtProt; NX_P49842; -.
DR   OpenTargets; ENSG00000204344; -.
DR   PharmGKB; PA36206; -.
DR   eggNOG; ENOG410IEVV; Eukaryota.
DR   eggNOG; ENOG410YGZ8; LUCA.
DR   GeneTree; ENSGT00390000018295; -.
DR   HOVERGEN; HBG056144; -.
DR   InParanoid; P49842; -.
DR   KO; K08880; -.
DR   OMA; RECPRRE; -.
DR   OrthoDB; EOG093706AL; -.
DR   PhylomeDB; P49842; -.
DR   TreeFam; TF105332; -.
DR   ChiTaRS; STK19; human.
DR   GeneWiki; STK19; -.
DR   GenomeRNAi; 8859; -.
DR   PRO; PR:P49842; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204344; -.
DR   CleanEx; HS_RP1; -.
DR   CleanEx; HS_STK19; -.
DR   ExpressionAtlas; P49842; baseline and differential.
DR   Genevisible; P49842; HS.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   InterPro; IPR018865; Ser/Thr_kinase_19.
DR   Pfam; PF10494; Stk19; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Manganese; Nucleotide-binding; Nucleus; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    368       Serine/threonine-protein kinase 19.
FT                                /FTId=PRO_0000072275.
FT   VAR_SEQ       1    110       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:8012361}.
FT                                /FTId=VSP_004432.
FT   VAR_SEQ     222    225       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:8012361,
FT                                ECO:0000303|PubMed:8132574}.
FT                                /FTId=VSP_004433.
FT   VARIANT      39     39       A -> D (in dbSNP:rs34843142).
FT                                /FTId=VAR_051387.
FT   VARIANT      89     89       D -> N (in a metastatic melanoma sample;
FT                                somatic mutation; dbSNP:rs267600971).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042361.
FT   VARIANT     311    311       S -> G (in dbSNP:rs616634).
FT                                {ECO:0000269|PubMed:14574404,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042362.
FT   VARIANT     331    331       A -> V (in dbSNP:rs7743647).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042363.
FT   MUTAGEN     300    300       K->P: Partial loss of activity.
FT   MUTAGEN     315    315       K->P: Partial loss of activity.
FT   MUTAGEN     317    317       K->P: Complete loss of activity.
FT   CONFLICT    195    197       QGE -> GQR (in Ref. 6; AAA99716).
FT                                {ECO:0000305}.
SQ   SEQUENCE   368 AA;  40916 MW;  A05AC847081DE8F8 CRC64;
     MQKWFSAFDD AIIQRQWRAN PSRGGGGVSF TKEVDTNVAT GAPPRRQRVP GRACPWREPI
     RGRRGARPGG GDAGGTPGET VRHCSAPEDP IFRFSSLHSY PFPGTIKSRD MSWKRHHLIP
     ETFGVKRRRK RGPVESDPLR GEPGSARAAV SELMQLFPRG LFEDALPPIV LRSQVYSLVP
     DRTVADRQLK ELQEQGEIRI VQLGFDLDAH GIIFTEDYRT RVCDCVLKAC DGRPYAGAVQ
     KFLASVLPAC GDLSFQQDQM TQTFGFRDSE ITHLVNAGVL TVRDAGSWWL AVPGAGRFIK
     YFVKGRQAVL SMVRKAKYRE LLLSELLGRR APVVVRLGLT YHVHDLIGAQ LVDCISTTSG
     TLLRLPET
//
